The chemical class known as RIMBP3 activators encompasses a diverse range of compounds that can engage in the modulation of the protein RIMBP3, a member of the Rab3-interacting molecule (RIM) binding protein family, which is implicated in synaptic transmission and plasticity. These activators exert their influence through various mechanisms, each acting upon different molecular targets within the neuronal signaling pathways. They can raise intracellular levels of second messengers such as cAMP, thereby influencing protein phosphorylation states that are crucial for synaptic function. Some of these activators can also directly bind to and modulate the activity of enzymes like protein kinases or phosphodiesterases, leading to alterations in the phosphorylation and activity of proteins that interact with RIMBP3, thus indirectly impacting its function.
Activators in this class can affect ion channel function and intracellular ion concentrations, fundamental aspects of neuronal excitability and signaling. The changes in ion flux can, in turn, trigger a cascade of intracellular events that influence synaptic plasticity and protein-protein interactions at the synapse. For instance, activators that impact calcium signaling can induce a range of downstream effects that are capable of modulating the activity of proteins such as RIMBP3. Additionally, some of these molecules can interact with receptor systems, possibly leading to changes in neurotransmitter release and synaptic strength, which are processes central to the role of RIMBP3 in the synapse. Collectively, the actions of RIMBP3 activators are integral to the fine-tuning of synaptic signaling and are crucial for the dynamic regulation of synaptic proteins, including RIMBP3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
cAMP analog, can mimic the effects of endogenous cAMP, could activate RIMBP3 by modulating phosphorylation states of interacting proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Green tea polyphenol, known to affect synaptic plasticity and could activate RIMBP3 through modulation of signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor, increases cAMP by preventing its breakdown, could activate RIMBP3 by altering phosphorylation patterns. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
L-type calcium channel activator, could activate RIMBP3 by enhancing calcium influx, potentially modulating synaptic protein interactions. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $28.00 $77.00 $142.00 $530.00 | 4 | |
Partial agonist at the glycine site of the NMDA receptor, could activate RIMBP3 by modulating synaptic plasticity. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulator of the ryanodine receptor, affects intracellular calcium release, could activate RIMBP3 through calcium-dependent signaling pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker, could activate RIMBP3 by modifying calcium signaling and influencing synaptic protein function. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Donor of nitric oxide, a signaling molecule that could activate RIMBP3 by modulating synaptic strength. | ||||||